Cargando…
Epigenetic modification of SALL1 as a novel biomarker for the prognosis of early stage head and neck cancer
This study examined Sal-like protein (SALL)1 methylation profiles in head and neck squamous-cell carcinoma (HNSCC) patients at diagnosis and follow-up, and evaluated their prognostic significance and value as a biomarker. SALL1 expression was examined in a panel of cell lines by quantitative reverse...
Autores principales: | Misawa, Kiyoshi, Misawa, Yuki, Imai, Atsushi, Mochizuki, Daiki, Endo, Shiori, Mima, Masato, Ishikawa, Ryuji, Kawasaki, Hideya, Yamatodani, Takashi, Kanazawa, Takeharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868161/ https://www.ncbi.nlm.nih.gov/pubmed/29581773 http://dx.doi.org/10.7150/jca.23527 |
Ejemplares similares
-
Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2017) -
Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation
por: Mochizuki, Daiki, et al.
Publicado: (2018) -
The neuropeptide genes SST, TAC1, HCRT, NPY, and GAL are powerful epigenetic biomarkers in head and neck cancer: a site-specific analysis
por: Misawa, Kiyoshi, et al.
Publicado: (2018) -
Association of TET3 epigenetic inactivation with head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2018) -
Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis
por: Misawa, Kiyoshi, et al.
Publicado: (2017)